Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion type Assertion NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_head.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion wasGeneratedBy ECO_0000203 NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_provenance.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion wasDerivedFrom befree-20140225 NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_provenance.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion SIO_000772 18536571 NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_provenance.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion evidence source_evidence_literature NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_provenance.
- NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_assertion description "[One possible pathomechanism causing leukemia is that clones of cells harboring acquired CSF3R mutations have a growth advantage over wild type cells in vivo during granulocyte-colony stimulating factor treatment due to activation of STAT5 and ss-catenin, both known to be involved in leukemogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280429.RArGv2GCETeO_tQrcyZoommQpneQUR9UKNmdCRNXpj-XM130_provenance.